Institute for Molecular Medicine Finland, HiLIFE University of Helsinki Finland.
Lipotype GmbH Dresden Germany.
J Am Heart Assoc. 2022 Oct 4;11(19):e027103. doi: 10.1161/JAHA.122.027103.
Background Despite well-recognized differences in the atherosclerotic cardiovascular disease risk between men and women, sex differences in risk factors and sex-specific mechanisms in the pathophysiology of atherosclerotic cardiovascular disease remain poorly understood. Lipid metabolism plays a central role in the development of atherosclerotic cardiovascular disease. Understanding sex differences in lipids and their genetic determinants could provide mechanistic insights into sex differences in atherosclerotic cardiovascular disease and aid in precise risk assessment. Herein, we examined sex differences in plasma lipidome and heterogeneity in genetic influences on lipidome in men and women through sex-stratified genome-wide association analyses. Methods and Results We used data consisting of 179 lipid species measured by shotgun lipidomics in 7266 individuals from the Finnish GeneRISK cohort and sought for replication using independent data from 2045 participants. Significant sex differences in the levels of 141 lipid species were observed (<7.0×10). Interestingly, 121 lipid species showed significant age-sex interactions, with opposite age-related changes in 39 lipid species. In general, most of the cholesteryl esters, ceramides, lysophospholipids, and glycerides were higher in 45- to 50-year-old men compared with women of same age, but the sex differences narrowed down or reversed with age. We did not observe any major differences in genetic effect in the sex-stratified genome-wide association analyses, which suggests that common genetic variants do not have a major role in sex differences in lipidome. Conclusions Our study provides a comprehensive view of sex differences in circulatory lipids pointing to potential sex differences in lipid metabolism and highlights the need for sex- and age-specific prevention strategies.
背景:尽管男性和女性的动脉粥样硬化性心血管疾病风险存在明显差异,但风险因素的性别差异以及动脉粥样硬化性心血管疾病病理生理学中的性别特异性机制仍知之甚少。脂质代谢在动脉粥样硬化性心血管疾病的发展中起着核心作用。了解脂质的性别差异及其遗传决定因素,可以为动脉粥样硬化性心血管疾病的性别差异提供机制上的见解,并有助于进行精确的风险评估。在此,我们通过按性别分层的全基因组关联分析,研究了男性和女性血浆脂质组中的性别差异以及脂质组中遗传影响的异质性。
方法和结果:我们使用了由芬兰 GeneRISK 队列中的 7266 个人的 shotgun 脂质组学测量得到的 179 种脂质组成的数据,并使用来自 2045 名参与者的独立数据进行了复制。观察到 141 种脂质的水平存在显著的性别差异(<7.0×10)。有趣的是,121 种脂质表现出显著的年龄-性别相互作用,其中 39 种脂质具有相反的与年龄相关的变化。一般来说,45 岁至 50 岁的男性的大多数胆固醇酯、神经酰胺、溶血磷脂和甘油三酯都高于同年龄段的女性,但随着年龄的增长,性别差异逐渐缩小或逆转。在按性别分层的全基因组关联分析中,我们没有观察到任何主要的遗传效应差异,这表明常见的遗传变异在脂质组的性别差异中没有主要作用。
结论:我们的研究提供了循环脂质性别差异的全面观点,指出脂质代谢可能存在潜在的性别差异,并强调需要制定针对性别和年龄的预防策略。
J Am Heart Assoc. 2022-10-4
Atherosclerosis. 2023-11
Cardiovasc Diabetol. 2024-3-29
Cell Mol Life Sci. 2021-3
Arterioscler Thromb Vasc Biol. 2022-1
Cell Mol Life Sci. 2021-3